Fibrinet: payments to doctors
Payments that named Fibrinet as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $330K
- Providers
- 249
- Transactions
- 863
- Average per transaction
- $382
The per-transaction average — $382 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 249 providers the average total is $1,323, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Royal Biologics, Inc. | $236,344 | 71.7% |
| Royal Biologics | $93,156 | 28.3% |